对头孢托罗培南和头孢洛林耐药的耐甲氧西林金黄色葡萄球菌
Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus.
作者信息
Chan Liana C, Basuino Li, Diep Binh, Hamilton Stephanie, Chatterjee Som S, Chambers Henry F
机构信息
Division of Infectious Disease, Department of Medicine, San Francisco General Hospital, San Francisco, California, USA Division of Molecular Medicine, Harbor-UCLA Medical Center, Torrance, California, USA
Division of Infectious Disease, Department of Medicine, San Francisco General Hospital, San Francisco, California, USA.
出版信息
Antimicrob Agents Chemother. 2015 May;59(5):2960-3. doi: 10.1128/AAC.05004-14. Epub 2015 Mar 9.
Abstract
The role of mecA mutations in conferring resistance to ceftobiprole and ceftaroline, cephalosporins with anti-methicillin-resistant Staphylococcus aureus (MRSA) activity, was determined with MRSA strains COL and SF8300. The SF8300 ceftaroline-passaged mutant carried a single mecA mutation, E447K (E-to-K change at position 447), and expressed low-level resistance. This mutation in COL conferred high-level resistance to ceftobiprole but only low-level resistance to ceftaroline. The COL ceftaroline-passaged mutant, which expressed high-level resistance to ceftobiprole and ceftaroline, had mutations in pbp2, pbp4, and gdpP but not mecA.
摘要
利用耐甲氧西林金黄色葡萄球菌（MRSA）菌株COL和SF8300，确定了mecA突变在赋予对头孢比普和头孢洛林（具有抗MRSA活性的头孢菌素）耐药性方面的作用。经头孢洛林传代的SF8300突变体携带单个mecA突变，即E447K（第447位发生E到K的变化），并表现出低水平耐药性。COL中的这种突变赋予对头孢比普的高水平耐药性，但仅对头孢洛林表现出低水平耐药性。对头孢比普和头孢洛林均表现出高水平耐药性的COL头孢洛林传代突变体在pbp2、pbp4和gdpP中存在突变，但mecA未发生突变。
相似文献
1
Ceftobiprole- and ceftaroline-resistant methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2015 May;59(5):2960-3. doi: 10.1128/AAC.05004-14. Epub 2015 Mar 9.
2
Characterization of an osteomyelitis case caused by dalbavancin, ceftaroline, and vancomycin non-susceptible methicillin-resistant Staphylococcus aureus.
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):2029-2032. doi: 10.1007/s10096-021-04219-0. Epub 2021 Mar 8.
3
Ceftaroline Resistance Selection of Methicillin-Resistant Involves Different Genetic Pathways.
Microb Drug Resist. 2019 Dec;25(10):1401-1409. doi: 10.1089/mdr.2019.0130. Epub 2019 Jul 19.
4
Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance.
Diagn Microbiol Infect Dis. 2019 Nov;95(3):114852. doi: 10.1016/j.diagmicrobio.2019.06.004. Epub 2019 Jun 15.
5
In vitro activity of ceftaroline and ceftobiprole against methicillin-resistant Staphylococcus aureus with decreased susceptibility to vancomycin isolated in paediatric patients.
J Chemother. 2018 Oct-Dec;30(6-8):338-341. doi: 10.1080/1120009X.2018.1522473. Epub 2018 Oct 30.
6
Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance.
PLoS One. 2016 Feb 18;11(2):e0149541. doi: 10.1371/journal.pone.0149541. eCollection 2016.
7
Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
J Antimicrob Chemother. 2016 Jan;71(1):41-4. doi: 10.1093/jac/dkv325. Epub 2015 Oct 5.
8
High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Isolates from a Hospital in Central Italy.
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01663-18. Print 2018 Dec.
9
Reduced In Vitro Activity of Ceftaroline by Etest among Clonal Complex 239 Methicillin-Resistant Staphylococcus aureus Clinical Strains from Australia.
Antimicrob Agents Chemother. 2015 Dec;59(12):7837-41. doi: 10.1128/AAC.02015-15. Epub 2015 Sep 21.
10
Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):343-350. doi: 10.1007/s10096-016-2807-5. Epub 2016 Oct 15.
引用本文的文献
1
Comparative Effects of Intermittent vs. Constant Ceftiofur Hydrochloride Exposure on In Vitro.
Antibiotics (Basel). 2025 Jul 6;14(7):686. doi: 10.3390/antibiotics14070686.
2
Cyclic-di-AMP modulates cellular turgor in response to defects in bacterial cell wall synthesis.
Nat Microbiol. 2025 Jun 17. doi: 10.1038/s41564-025-02027-2.
3
Evidence of -mediated β-lactam antibiotic resistance transfer to from sp. nov., a psychrophilic bacterium from food-producing animals and human clinical specimens.
Appl Environ Microbiol. 2025 Apr 23;91(4):e0165224. doi: 10.1128/aem.01652-24. Epub 2025 Mar 11.
4
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics.
Nat Rev Microbiol. 2024 Oct;22(10):598-616. doi: 10.1038/s41579-024-01054-w. Epub 2024 Jun 3.
5
Reducing Peptidoglycan Crosslinking by Chemical Modulator Reverts β-lactam Resistance in Methicillin-Resistant Staphylococcus aureus.
Adv Sci (Weinh). 2024 Jul;11(28):e2400858. doi: 10.1002/advs.202400858. Epub 2024 May 15.
6
Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in .
mBio. 2024 May 8;15(5):e0288923. doi: 10.1128/mbio.02889-23. Epub 2024 Mar 26.
7
Molecular Determinants of β-Lactam Resistance in Methicillin-Resistant (MRSA): An Updated Review.
Antibiotics (Basel). 2023 Aug 24;12(9):1362. doi: 10.3390/antibiotics12091362.
8
Structural basis of broad-spectrum β-lactam resistance in Staphylococcus aureus.
Nature. 2023 Jan;613(7943):375-382. doi: 10.1038/s41586-022-05583-3. Epub 2023 Jan 4.
9
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
Microbiol Spectr. 2023 Feb 14;11(1):e0372622. doi: 10.1128/spectrum.03726-22. Epub 2022 Dec 15.
10
Inhibition of the Quorum Sensing System, Elastase Production and Biofilm Formation in by Psammaplin A and Bisaprasin.
Molecules. 2022 Mar 6;27(5):1721. doi: 10.3390/molecules27051721.
本文引用的文献
1
PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.
Antimicrob Agents Chemother. 2014 Nov;58(11):6668-74. doi: 10.1128/AAC.03622-14. Epub 2014 Aug 25.
2
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
J Antimicrob Chemother. 2014 Aug;69(8):2065-75. doi: 10.1093/jac/dku114. Epub 2014 Apr 28.
3
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function.
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16808-13. doi: 10.1073/pnas.1300118110. Epub 2013 Oct 1.
4
Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.
Expert Rev Anti Infect Ther. 2012 Oct;10(10):1087-103. doi: 10.1586/eri.12.112. Epub 2012 Nov 21.
5
Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole.
J Biol Chem. 2012 Sep 14;287(38):32096-102. doi: 10.1074/jbc.M112.355644. Epub 2012 Jul 19.
6
Improving known classes of antibiotics: an optimistic approach for the future.
Curr Opin Pharmacol. 2012 Oct;12(5):527-34. doi: 10.1016/j.coph.2012.06.003. Epub 2012 Jun 28.
7
Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
J Antimicrob Chemother. 2012 Jun;67(6):1321-4. doi: 10.1093/jac/dks069. Epub 2012 Mar 7.
8
Ceftaroline fosamil: a novel broad-spectrum cephalosporin.
Drugs Today (Barc). 2010 Oct;46(10):743-55. doi: 10.1358/dot.2010.46.10.1519172.
9
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole.
Ther Clin Risk Manag. 2010 Oct 5;6:485-95. doi: 10.2147/TCRM.S5823.
10
A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level β-lactam resistance contains mutations in three genes.
Antimicrob Agents Chemother. 2010 Nov;54(11):4900-2. doi: 10.1128/AAC.00594-10. Epub 2010 Aug 30.
Zotero 插件